Medtronic beats Q1 estimates, lifts FY27 outlook on broad growth

Medtronic reported Q1 FY27 adjusted EPS of $1.45 on revenue of $9.76B, both above consensus. The company raised its full-year adjusted EPS guidance to $5.94-$6.00 and organic growth outlook to 7.25%-7.75%. It also announced a ~$700M partnership with Cornerstone Robotics for surgical robots.